期刊文献+

胃癌组织Ki-67和pAKT表达相关性的研究 被引量:5

Correlation between the expression of Ki-67 and pAKT in gastric carcinoma tissues
原文传递
导出
摘要 目的:探讨细胞核增殖指数(Ki-67)、丝氨酸/苏氨酸蛋白激酶(pAKT)在胃癌组织中的表达及与胃癌侵袭转移和复发等生物学行为的关系。方法:收集有完整临床病理资料、经手术及术后病理学确诊的60例胃癌患者作为观察组,并以20例癌旁异型增生胃黏膜组织和20例活检正常胃黏膜组织作为对照组,应用免疫组织化学SP法检测Ki-67、pAKT的表达,用CD31标记血管计数MVD,比较:1)Ki-67、pAKT的表达在胃癌、癌旁组织和正常胃黏膜组织中的表达差异;2)与肿瘤分化程度的关系;3)与癌组织浸润深度和转移的关系。结果:观察组中Ki-67(73.3%,44/60)、pAKT(75.0%,48/64)的表达明显高于对照组癌旁异型组织(35.0%,7/20)和正常黏膜组织(10.0%,2/20),差异有统计学意义,χ2=9.538,P=0.002;χ2=24.621,P=0.000。Ki-67、pAKT在高级别与低级别胃癌组织中的表达差异有统计学意义,P<0.05。Ki-67、pAKT在进展期胃癌显著上调,与早期癌表达差异有统计学意义,P<0.05。Ki-67、pAKT与癌组织淋巴结转移有关,P<0.05。结论:Ki-67、pAKT异常表达与胃癌的发生、发展密切相关,在胃癌组织中表达上调,促进了肿瘤形成、发展、侵袭和转移,Ki-67、pAKT检测对于判断胃癌生物学行为有一定的价值,可作为临床参考指标。 OBJECTIVE: To investigate the expression of Ki-67 and pAKT in gastric carcinoma and their relationship with invasion and metastasis. METHODS: Sixty cases of gastric carcinoma with complete clinical datas and diagnosed by pathology intraoperatively and postoperatively were collected as the observation group. The expressions of Ki-67, pAKT were measured by immunohistochemical UltraSensitiveTM SP method staining in 60 cases of primary gastric carcinoma, 20 cases of dysplasia tissue closely adjacent to carcinomas, and 20 cases of normal gastric mucosa specimens. RESULTS: The expressions of Ki-67 and pAKT in gastric cancer were (73.3 % ,44/60) and(75.0 %,48/64) repectively, the expressions of Ki-67 and pAKT in gastric tissues obviously was higher than the expression in adjacent tissue organizations(35.0%, 7/10) and normalmucosaltissue (10.0%, 2/20,X2=9.538,P=0.002;x2=24. 621,P=0. 000). The expression of Ki- 67, pAKT was positively correlated to the infiltration of gastric and lymph node metastasis (P〈0.05). CONCLUSIONS: The occurrence and development of gastric carcinoma may be closely related to the expression of Ki-67, pAKT. The ab normal expression of Ki-67 and pAKT play an important role in the genesis and development of gastric carcinoma and may be responsible for the enhanced activity in tumor-induced neovascularization, invasion and metastasis. Ki 67, pAKT have positively expressive correlation and may serve as valuable indicators of biological behavior of gastric carcinoma.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2012年第15期1156-1158,共3页 Chinese Journal of Cancer Prevention and Treatment
  • 相关文献

参考文献4

二级参考文献22

  • 1Grothey A, Voigt W, Schober C, et al. The role of insulin like growth factor-1 and its receptor in cell growth, transformation, apoptosis, and chemoresistance in solid tumors[J]. J Cancer Res Clin Oncol, 1999, 125(3/4):166-173.
  • 2Baserga R, Peruzzi F, Reiss K. The IGF-1 receptor in cancer bi ology[J]. Int J Cancer, 2003,107(6):873-877.
  • 3Werner H, LeRoith D. New concepts in regulation and function of the insulin like growth factors: implications for understanding normal growth and neoplasia[J]. Cell Mol Life Sci, 2000, 57 (6) :932-942.
  • 4Vivanco I, Sawyers C L. The phosphatidylinositol 3-kinase AKT pathway in human cancer[J]. Nat Rev Cancer, 2002, 2 (7) :489- 501.
  • 5Krueger J S, Keshamouni V G, Atanaskova N, et al. Temporal and quantitative regulation of mitogen activated protein kinase (MAPK) modulates cell motility and invasion, invasion[J]. On cogene, 2001,20(31):4209-4218.
  • 6Dews M, Prisco M, Peruzzi F, et al. Domains of the insulin-like growth factor I receptor required for the activation of extracellu lar signal-regulated kinases [J]. Endocrinology, 2000, 141 (4):1289-300.
  • 7Vicent S, Lopez-Picazo J M, Toledo G, et al. ERK1/2 is activated in Non-small-cell lung cancer and associated with advanced tumors[J]. Br J Cancer,2004,90(5):1047-1052.
  • 8Sebolt Leopold J S, Herrera R. Targeting the mitogen activated protein kinase cascade to treat cancer[J]. Nat Rev Cancer, 2004,4(12) :937-947.
  • 9Blum G, Gazit A, Levitzki A. Development of new insulin like growth factor-1 receptor kinase inhibitors using catechol mimics [J]. J Biological Chemistry, 2008,278(42):40442-40454.
  • 10Girnita A, Girnita L, Prete F D, et al. Cyclolignans as inhibi tors of the insulin-like growth factor-1 receptor and malignant cellgrowth[J]. Cancer Res, 2004,64(1): 236-242.

共引文献49

同被引文献30

  • 1Chao He,Xue-Yi Bian,Xing-Zhi Ni,Dan-Ping Shen,Yan-Ying Shen,Hua Liu,Zhi-Yong Shen,Qiang Liu.Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer[J].World Journal of Gastroenterology,2013,19(14):2171-2178. 被引量:29
  • 2刘振虹,梅立新,杜军英,金小平.肺癌组织中PTEN基因表达的临床意义[J].中国综合临床,2005,21(2):169-170. 被引量:6
  • 3陈峻青.胃癌根治术后复发形式和治疗方法的选择[J].中国实用外科杂志,1995,15(12):709-710. 被引量:55
  • 4Rex DK, Kahi C J, Levin B, et al. Guidelines tor colonoscopy surveillance alter cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer [ J ]. CA Cancer J Clin,2006,56 ( 3 ) : 160-167,185-186.
  • 5Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer [J]. Cancer Res,1998,58(22) :5071-5074.
  • 6Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer [ J ]. Science, 1997,275 ( 5308 ) : 1943-1947.
  • 7Tamura M, Gu J, Tran H, et al. PTEN gene and integrin signaling in cancer [J ]. J Natl Cancer Inst, 1999,91 ( 21 ) : 1820 - 1828.
  • 8Salmena L, Carracedo A, Pandolfi PP. Tenets of PTEN tumor suppression [ J ]. Ce11,2008,133 (3) :403-414.
  • 9Gerdes J, Lernke H, Baiseh H, et al. Cell cycle analysis of a cell proliferation-assoeiated human nuclear antigen defined by themonoclonal antibody Ki-67 [J]. J Immunol, 1984,133 (4) :1710- 1715.
  • 10Capparelli C,Whitaker Menezes D,Guido C. CTGF drives autophagy,glycolysis and senescence in cancer associated fibroblasts via HIF1 activation,metabolically promoting tumor growth[J].Cell Cycle,2012,(12):2272-2284.

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部